Insiders · Profile

INGRAM ROBERT ALEXANDER

Director at Black Diamond Therapeutics · Director at BIOCRYST PHARMACEUTICALS · Director at WOLFSPEED · and 4 more. Filing since 21 May 2008. CIK 0001219890

Company
Date
Role
Action
Shares
Amount
Of holding
30 Sep 2020
Director
Bought
5,000
$152.29K
opened
18 Nov 2019
Director
Bought
20,000
$29.00K
71.2%
1 Dec 2015
Director
Sold, plan not stated
3,750
$103.76K
7.1%
27 May 2015
Director
Sold, plan not stated
1,379
$707.96K
47.9%
31 Jul 2014
Director
Sold, plan not stated
12,500
$1.13M
29.0%
25 May 2012
Director
Sold, plan not stated
15,000
$1.32M
28.9%
9 May 2011
Director
Sold, plan not stated
10,000
$877.90K
17.8%
28 Feb 2011
Director
Sold, plan not stated
9,872
$394.88K
100%
30 Nov 2010
Director
Sold, plan not stated
5,000
$331.65K
8.2%
16 Nov 2010
Director
Sold, plan not stated
4,590
$298.35K
7.0%
27 May 2010
Director
Sold, plan not stated
8,000
$197.40K
100%
6 Mar 2009
Director
Bought
1,000
$18.95K
26.7%
21 May 2008
Director
Sold, plan not stated
8,000
$191.49K
100%
13 decisions on file.